SG Americas Securities
BIVV

SG Americas Securities’s Bioverativ Inc. Common Stock BIVV Stock Holding History

SG Americas Securities’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-32,850
Closed -$1.77M – 3735
2017
Q4 		$1.77M Buy
32,850
+27,113
+473% +$1.48M 0.02% 992
2017
Q3 		$327K Sell
5,737
-15,291
-73% -$896K ﹤0.01% 2168
2017
Q2 		$1.26M Buy
21,028
+5,290
+34% +$301K 0.01% 1227
2017
Q1 		$857K Buy
+15,738
New +$775K 0.01% 1484

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

SG Americas Securities's BIVV Position: Q1 2018 in Review

SG Americas Securities sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 32,850 shares — an estimated $1.77M sold.

SG Americas Securities first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1.77M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • SG Americas Securities reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • SG Americas Securities sold 32,850 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1.77M.
  • SG Americas Securities first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • SG Americas Securities's Bioverativ Inc. Common Stock position peaked at $1.77M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on SG Americas Securities's 13F filing for Q1 2018, filed 3 May 2018.